Improving cancer screening in the EU
For HCPs only MC-HR-01720
This author has yet to write their bio.Meanwhile lets just say that we are proud Hana Gasper contributed a whooping 3 entries.
For HCPs only MC-HR-01720
For HCPs only MC-HR-01719
The Roche Cervical Cancer Portfolio provides three clinically validated tests to help identify women at risk and improve detection and confirmation of high-grade disease in a single round of screening. The powerful combination of these tests supports healthcare professionals in making decisions for their patients with confidence. The landmark ATHENA clinical study helped shape our […]
Disclaimer
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
This web page is not intended for reporting adverse drug reactions and other safety information.
Slovenia
Please report the suspected adverse reactions that you notice during drug therapy in accordance with the Rules on the Pharmacovigilance of medicinal products for human use (Official Gazette of the Republic of Slovenia, No. 57/14 and 27/17), in the way it is published on the website www.jazmp.si.
Roche contacts for collecting safety information regarding Roche medicinal products: slovenia.drugsafety@roche.com.
Croatia
Please report the suspected adverse reactions that you notice during drug therapy in accordance with the Ordinance on Monitoring Adverse Incidents Related to Medical Devices (Official Gazette, no. 125/13) in the way it is published on the website http://www.halmed.hr/
Roche contacts for collecting safety information regarding Roche medicinal products: croatia.drugsafety@roche.com.
Bosnia and Herzegovina
Please report the suspected adverse reactions that you notice during drug therapy in accordance with the Ordinance On Advertising Of Medicinal Products And Medical Devices (Official Gazette, no. 58/12) in the way it is published on the website http://www.almbih.gov.ba/
Roche contacts for collecting safety information regarding Roche medicinal products: bosnia.drugsafety@roche.com.
You are about to leave the Roche website. The website which you intend to visit is operated by a third party. The link to this web site is not offering any representation or warranty for the products and services available on the third party website and is intended solely to grant access to the third party web sites. Do you wish to proceed?